Expansion Technologies, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Expansion Technologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $500,000 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2017.
Expansion Technologies at a glance
What does Expansion Technologies do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $500,000 in total (2022). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1.5 million sold (2017).
Frequently asked questions about Expansion Technologies
Where is Expansion Technologies headquartered?
Expansion Technologies, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Expansion Technologies do?
Expansion Technologies, Inc. is a biotechnology company.
When was Expansion Technologies founded?
The earliest incorporation on record for Expansion Technologies, Inc. is in 2015, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences